| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/05/1987 | US4663311 Derivatives of muramyl-peptides and of steroids having macrophage-activating properties |
| 05/05/1987 | US4663307 Anti-allergic and anti-thromboembolic 6H-dibenz-[b,e][1,4]-oxathiepin derivatives, compositions, and method of use therefor |
| 05/05/1987 | US4663289 Tissue culture, cell preservation |
| 05/05/1987 | US4663166 Electrolyte solutions and in vivo use thereof |
| 05/05/1987 | US4663154 Oral compositions |
| 05/05/1987 | US4663150 Theophylline and derivatives |
| 05/05/1987 | US4662880 Pseudoephedrine, brompheniramine therapy |
| 05/05/1987 | CA1221369A1 Synthesis of nizatidine |
| 05/05/1987 | CA1221366A1 Orthocondensed pyrrole derivatives, their preparation and their use in novel medicinal products |
| 05/05/1987 | CA1221356A1 .beta.-LACTAM COMPOUNDS, THEIR PREPARATION AND USE |
| 05/05/1987 | CA1221309A1 Compositions for the treatment of psoriasis |
| 05/05/1987 | CA1221308A1 N-acetyl-p-aminophenol composition containing partially gelatinized starch and method for preparing same |
| 04/30/1987 | DE3538142A1 Combination preparations of analgesics and their use |
| 04/29/1987 | EP0220153A1 A nutritive emulsion having oxygen-transporting properties, and process for its preparation |
| 04/29/1987 | EP0220143A1 New pharmaceutical preparation with controlled release of metoprolol, a method for the manufacture thereof and the use of the new preparation |
| 04/29/1987 | EP0220129A2 12- and 13-substituted ergoline derivatives |
| 04/29/1987 | EP0220118A2 Bicyclic naphthalenic derivatives, process for their preparation and their use in human and veterinary medicine and cosmetics |
| 04/29/1987 | EP0220112A2 Aromatic derivatives substituted by an (omega-amino)-alkanol group with an antimicrobial activity, their preparation and compositions containing them |
| 04/29/1987 | EP0220107A2 Use of angiotensin-converting enzyme inhibitors in macular degeneration |
| 04/29/1987 | EP0220104A2 5-Amino-pentanenitrile derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 04/29/1987 | EP0220066A2 Carboxamide derivatives |
| 04/29/1987 | EP0220065A2 Trichothecene conjugates |
| 04/29/1987 | EP0220030A2 Oral delivery system |
| 04/29/1987 | EP0220011A2 Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia |
| 04/29/1987 | EP0219961A1 Irreversible dopamine-B-hydroxylase inhibitors |
| 04/29/1987 | EP0219947A2 Use of 1-methyl-2-methylsulphonyl-4-nitroimidazole as an antiprotozoal and antibacterial agent |
| 04/29/1987 | EP0219934A1 Process for the preparation of aryl-piperidine esters |
| 04/29/1987 | EP0219929A1 Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones |
| 04/29/1987 | EP0219926A2 Cephalosporins, processes for their preparation and pharmaceutical compositions containing them |
| 04/29/1987 | EP0219922A2 Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles |
| 04/29/1987 | EP0219912A2 The use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders |
| 04/29/1987 | EP0219898A1 Novel alpha,alpha-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, N-oxides |
| 04/29/1987 | EP0219896A1 Pharmaceutical compositions on the basis of dextrorphan for intranasal application |
| 04/29/1987 | EP0219876A2 Antihypertensive agents comprising 2-alkynyladenosines as active ingredients |
| 04/29/1987 | EP0219852A2 Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for producing the same |
| 04/29/1987 | EP0219829A2 2-Fluoro-arabinofuranosyl purine nucleosides |
| 04/29/1987 | EP0219813A1 Bicyclo-substituted phenylacetonitrile derivatives |
| 04/29/1987 | EP0219784A2 Infusion solutions of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-chinolon-3-carboxylic acid |
| 04/29/1987 | EP0219782A2 Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease |
| 04/29/1987 | EP0219747A1 2-(2-Thienyl)-imidazo(4,5-c)pyridine derivatives and their salts, process for their preparation and pharmaceutical preparations containing them |
| 04/29/1987 | EP0219737A1 Preparation on the basis of a mixture |
| 04/29/1987 | EP0219728A1 Preparation on the basis of a mixture |
| 04/29/1987 | EP0219706A1 N,N-dialkylaminoalkyl-hexahydro-5-oxo-1H-pyrrolizine-3-carboxamides |
| 04/29/1987 | EP0219651A1 Inorganic acid salt of N-[1(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanylchloride and process for preparing the same |
| 04/29/1987 | EP0219625A1 Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones |
| 04/29/1987 | EP0219514A1 Method of preventing diseases caused by gram-negative endotoxin in mammals |
| 04/29/1987 | EP0219505A1 Stereoselective process and chiral intermediates for aryloxydropanolamines. |
| 04/29/1987 | EP0219491A1 Oxindole alkaloids with properties stimulating the immunity system and preparations containing them. |
| 04/29/1987 | CN86107491A Novel quinoline derivatives and processes for preparation thereof |
| 04/29/1987 | CN86105088A Gem-dihalo and tetrahalo-1, 12-diamino-4, 9-diaza-dodecanes |
| 04/29/1987 | CN86103850A Process for the preparation of large ring lactone antibiotic compounds |
| 04/28/1987 | US4661636 6-sulfoxyphenol derivatives, their preparation and their use as cytoprotective agents |
| 04/28/1987 | US4661630 Nervous system disorders |
| 04/28/1987 | US4661618 Stimulation of brain cells and mental activity; antiaging agents |
| 04/28/1987 | US4661592 Anorectic agents |
| 04/28/1987 | US4661590 Bactericides |
| 04/28/1987 | US4661524 4-(6-substituted-2-naphthyl)-2-butanones or -butanols, antiinflammatory |
| 04/28/1987 | US4661522 Anticoagulants |
| 04/28/1987 | US4661521 Direct tableting acetaminophen compositions |
| 04/28/1987 | US4661520 Cyanoguanidine useful as an animal growth promoting agent |
| 04/28/1987 | US4661519 Method for dermatological application |
| 04/28/1987 | US4661514 Pharmaceutical and veterinary compositions for the treatment of ischemic cardiac disorders |
| 04/28/1987 | US4661513 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them |
| 04/28/1987 | US4661512 Adamantanamine derivatives, processes for their preparation and drugs in which they are present |
| 04/28/1987 | US4661511 2-(hydroxy-phenyl)-indoles and process for their production |
| 04/28/1987 | US4661509 Methods for treating leukopenia |
| 04/28/1987 | US4661507 Antifungal S-ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols and corresponding sulfoxides and sulfones |
| 04/28/1987 | US4661506 7-oxabicycloheptane substituted ox prostaglandin analogs |
| 04/28/1987 | US4661505 4-(4-acetyl-3-hydroxy-2-propylphenoxy) alkanoic acids, tetrazoles, and derivatives |
| 04/28/1987 | US4661502 Enzyme inhibitors |
| 04/28/1987 | US4661500 Method of medical treatment with serotonin antagonists |
| 04/28/1987 | US4661498 Furo 3,2-c pyridine derivatives and their use in treating depression and cerebral ischemia |
| 04/28/1987 | US4661495 Arphamenine-related compounds useful for potentiating the immune response in a living animal |
| 04/28/1987 | US4661493 Tioconazole and related compounds for control of Herpes simplex virus |
| 04/28/1987 | US4661492 Buprenorphine and naltrexone |
| 04/28/1987 | US4661491 Alfuzosine compositions and use |
| 04/28/1987 | US4661490 Treatment with dialkoxy pyridopyrimidines |
| 04/28/1987 | US4661487 Cardiovascular disorders |
| 04/28/1987 | US4661485 2-pyrimidylaminoalkoxymethyl-6-methyl-3,5-bis (alkoxycarbony-1)-1,4-dihydropyridine antihypertensive agents |
| 04/28/1987 | US4661484 Pyridazinone derivatives and salts thereof as cardiac stimulants |
| 04/28/1987 | US4661482 Use of pyrazolobenzoxazines in method of treating cerebral senescence and cerebral hypoxin |
| 04/28/1987 | US4661478 Administering 5-methyl-3-sulfanilamido-isoxazole and 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine |
| 04/28/1987 | US4661473 Hypotensive agents |
| 04/28/1987 | US4661469 t-PA composition capable of being absorbed into the blood stream and method of administration |
| 04/28/1987 | US4661345 Method for treating pertussis |
| 04/28/1987 | US4661342 Anticaries agents |
| 04/28/1987 | US4661297 Basic ethers of 7-oxo-7H-benzo(c) fluorene and a process for their production |
| 04/28/1987 | US4661114 Couplers |
| 04/28/1987 | CA1221091A1 Process for the stabilization of hematin |
| 04/28/1987 | CA1221090A1 Preparation of xylane sulfates, and sulfates thus prepared |
| 04/28/1987 | CA1221032A1 Composition for reducing sebum secretion |
| 04/28/1987 | CA1221031A1 Use of a cholecalciferol derivative |
| 04/28/1987 | CA1221028A1 Material for use in the treatment of spontaneous abortions |
| 04/23/1987 | WO1987002365A2 Process for preparing netilmicin |
| 04/23/1987 | WO1987002364A1 Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
| 04/23/1987 | WO1987002361A1 Substituted 4-benzyl-piperazinyl compounds |
| 04/23/1987 | WO1987002251A1 Oral delivery of biologically active substances bound to vitamin b12, or analogues thereof |
| 04/23/1987 | WO1987002247A1 Rapid acting intravenous emulsions of omega-3 fatty acid esters |
| 04/23/1987 | WO1987002246A1 Method for reducing the risk or probability of infection from the aids virus (htlv-iii/lav/arv) |
| 04/23/1987 | WO1987002244A1 Tissue growth regulation |